Outcomes and Prognosis of COVID-19-Induced ARDS Patients Treated with Prolonged VV-ECMO: A Retrospective Multicenter Study
How to cite: Bitan, A.; Sagie, N.; Ilgiyaev, E.; Stavi, D.; Makhoul, M.; Soroksky, A.; Kasif, Y.; Novack, V.; Galante, O. Outcomes and Prognosis of COVID-19-Induced ARDS Patients Treated with Prolonged VV-ECMO: A Retrospective Multicenter Study. Preprints 2024, 2024110259. https://doi.org/10.20944/preprints202411.0259.v1 Bitan, A.; Sagie, N.; Ilgiyaev, E.; Stavi, D.; Makhoul, M.; Soroksky, A.; Kasif, Y.; Novack, V.; Galante, O. Outcomes and Prognosis of COVID-19-Induced ARDS Patients Treated with Prolonged VV-ECMO: A Retrospective Multicenter Study. Preprints 2024, 2024110259. https://doi.org/10.20944/preprints202411.0259.v1
Abstract
Background: Predicting whether extracorporeal membrane oxygenation (ECMO) treatment duration affects prognosis is important both medically and economically. We conducted a retrospective, multicenter study to better understand the outcomes of patients treated with VV ECMO for a prolonged duration, analyzing data from the Israel ECMO registry. The study included all adult patients treated with VV-ECMO due to COVID-19-induced respiratory failure. The primary outcomes were survival rates up to 180 days from cannulation. Results: One hundred and eighty-eight patients were included in the study. The median age was 50 years (IQR 42, 50) and 69% were male. Patients were mechanically ventilated for a median of 2.5 days before cannulation (IQR 0.5, 5). The mean ECMO support duration was 29.9 days, with a maximal duration of 189.9 days. Survival rate for 180 days was 56%. We found no change in survival for patients on ECMO for 14, 28, or 56 days. Every day of mechanical ventilation before cannulation correlated with an 11% greater risk for prolonged ECMO treatment (p=0.01). Conclusions: For COVID-19-induced ARDS patients treated with VV-ECMO, ECMO treatment duration did not affect mortality. The longer the duration of mechanical ventilation before ECMO cannulation, the higher the risk for prolonged ECMO treatment.
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)